quinazolines has been researched along with naphthoquinones in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (28.57) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 1 (7.14) | 29.6817 |
| 2010's | 7 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, JS; Lendner, G; Sanft, S; Schein, E | 1 |
| Canfield, CJ; Rozman, RS | 1 |
| Ahmed, JS; Rehbein, G; Zweygarth, E | 1 |
| McHardy, N; Morgan, DW | 1 |
| Raghav, PR; Singh, DK; Thakur, M; Varshney, BC | 1 |
| Mehlhorn, H; Schein, E | 1 |
| Cho, H; Hwang, JH; Jeong, D; Kang, HK; Kim, GD; Kong, JY; Lee, KI; Lee, S; Lee, SJ; Park, SJ; Park, WK; Park, Y | 1 |
| Hatashita, E; Kita, A; Kuwata, K; Nakagawa, K; Okamoto, I; Okamoto, K; Ono, M; Yamaguchi, H; Yamanaka, K | 1 |
| Li, W; Wu, L; Zhang, C | 1 |
| Elemento, O; Kapoor, TM; Kasap, C | 1 |
| Bauer, R; Efferth, T; Kretschmer, N; Zhao, Q | 1 |
| Chow, LW; Fan, XX; Jiang, ZB; Leung, EL; Li, X; Liu, L; Loo, WT; Yao, XJ | 1 |
| Chang, CC; Chang, J; Chang, YC; Chang, YF; Cheng, CC; Ho, AS; Huang, L; Huang, SC; Lim, KH; Lin, HC; Wu, CW | 1 |
| Chen, JY; Jiang, Z; Long, F; Ren, YG; Tang, JC; Zhao, J | 1 |
1 trial(s) available for quinazolines and naphthoquinones
| Article | Year |
|---|---|
Clinical testing of new antimalarial compounds.
Topics: Amino Acids; Antimalarials; Clinical Trials as Topic; Drug Evaluation; Drug Resistance; Guanidines; Humans; Malaria; Naphthoquinones; Phenanthrenes; Plasmodium falciparum; Pteridines; Pyridines; Pyrimidines; Quinazolines; Quinolines; Sulfones; Triazines; Xylenes | 1974 |
13 other study(ies) available for quinazolines and naphthoquinones
| Article | Year |
|---|---|
Effect of chemotherapy on the biological functions of lymphoblastoid cells infected with Theileria annulata.
Topics: Animals; Antiprotozoal Agents; Apicomplexa; Lymphocytes; Naphthoquinones; Quinazolines; Quinazolinones; Theileriasis; Triazines | 1987 |
The effect of halofuginone, Wellcome 993 C, oxytetracycline, and diminazene diaceturate on Babesia equi-infected lymphoblastoid cell cultures.
Topics: Amidines; Animals; Antiprotozoal Agents; Babesia; Cell Line; Diminazene; DNA; Lymphocytes; Naphthoquinones; Oxytetracycline; Piperidines; Quinazolines; Quinazolinones; Thymidine | 1984 |
Comparison of the antitheilerial effect of Wellcome 993C and halofuginone.
Topics: Animals; Antiprotozoal Agents; Apicomplexa; Cattle; Coccidiostats; Lymph Nodes; Male; Naphthoquinones; Piperidines; Quinazolines; Quinazolinones; Theileriasis | 1982 |
Chemotherapeutic trials with four drugs in crossbred calves experimentally infected with Theileria annulata.
Topics: Animals; Antiprotozoal Agents; Cattle; Male; Naphthoquinones; Oxytetracycline; Quinazolines; Quinazolinones; Theileria annulata; Theileriasis | 1993 |
Redescription of Babesia equi Laveran, 1901 as Theileria equi Mehlhorn, Schein 1998.
Topics: Animals; Antiprotozoal Agents; Arachnid Vectors; Babesia; Erythrocytes; Horse Diseases; Horses; Life Cycle Stages; Lymphocytes; Naphthoquinones; Piperidines; Quinazolines; Quinazolinones; Theileria; Theileriasis; Ticks | 1998 |
Naphthofuroquinone derivatives: inhibition of receptor tyrosine kinases.
Topics: Enzyme Inhibitors; ErbB Receptors; Furans; Naphthoquinones; Quinazolines; Receptor Protein-Tyrosine Kinases; Receptors, Vascular Endothelial Growth Factor; Structure-Activity Relationship | 2006 |
Overcoming erlotinib resistance in EGFR mutation-positive non-small cell lung cancer cells by targeting survivin.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Humans; Imidazoles; Inhibitor of Apoptosis Proteins; Mice; Mice, Nude; Naphthoquinones; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Quinazolines; RNA Interference; RNA, Small Interfering; Signal Transduction; Survivin | 2012 |
Regioselective synthesis of 6-aryl-benzo[h][1,2,4]-triazolo[5,1-b]quinazoline-7,8-diones as potent antitumoral agents.
Topics: Aldehydes; Antineoplastic Agents; Catalysis; Cell Line, Tumor; Hep G2 Cells; Humans; Naphthoquinones; Neoplasms; Quinazolines; Sulfonic Acids; Triazoles | 2013 |
DrugTargetSeqR: a genomics- and CRISPR-Cas9-based method to analyze drug targets.
Topics: Antineoplastic Agents; Benzamides; Cell Line, Tumor; Clustered Regularly Interspaced Short Palindromic Repeats; Drug Resistance, Neoplasm; Endonucleases; Epigenesis, Genetic; Genome; High-Throughput Nucleotide Sequencing; Humans; Imidazoles; Kinesins; Molecular Targeted Therapy; Mutation; Naphthoquinones; Quinazolines | 2014 |
Shikonin and its derivatives inhibit the epidermal growth factor receptor signaling and synergistically kill glioblastoma cells in combination with erlotinib.
Topics: Anthraquinones; Antineoplastic Combined Chemotherapy Protocols; Cell Line, Tumor; Drug Synergism; ErbB Receptors; Erlotinib Hydrochloride; Glioblastoma; Humans; Mitogen-Activated Protein Kinases; Naphthoquinones; Phosphorylation; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction | 2015 |
Shikonin inhibits gefitinib-resistant non-small cell lung cancer by inhibiting TrxR and activating the EGFR proteasomal degradation pathway.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Drug Resistance, Neoplasm; ErbB Receptors; Gefitinib; High-Throughput Screening Assays; Humans; Lung Neoplasms; Mutation; Naphthoquinones; Neoplasm Recurrence, Local; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; Signal Transduction; Thioredoxin-Disulfide Reductase | 2017 |
YM155 as an inhibitor of cancer stemness simultaneously inhibits autophosphorylation of epidermal growth factor receptor and G9a-mediated stemness in lung cancer cells.
Topics: Afatinib; Antineoplastic Agents; Cell Line, Tumor; Drug Evaluation, Preclinical; ErbB Receptors; Gene Expression Regulation, Neoplastic; Histocompatibility Antigens; Histone-Lysine N-Methyltransferase; Humans; Imidazoles; Lung Neoplasms; Methylation; Naphthoquinones; Octamer Transcription Factor-3; Phosphorylation; Quinazolines; RNA, Messenger | 2017 |
Shikonin enhances sensitization of gefitinib against wild-type EGFR non-small cell lung cancer via inhibition PKM2/stat3/cyclinD1 signal pathway.
Topics: A549 Cells; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Line, Tumor; Cell Survival; Cyclin D1; Drug Synergism; ErbB Receptors; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Membrane Proteins; Mice; Mice, Nude; Naphthoquinones; Quinazolines; Signal Transduction; Sincalide; STAT3 Transcription Factor; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2018 |